The aim of the study is to analyze the plasmatic profile of IL-6, TNF-α, and IL-10 in patients with NASH, which can be considered targets that modulate oxidative stress and inflammation. Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.